Clin2
NCT06672653Possibly a fitNot yet recruiting

Testing C14 for HPV infection in women

HPV-induced CancersHPV InfectionsHIVCervical CancersTrialC14Monoterpenoid Zinc Tetra-ascorbo-camphorate

Part of Cancer, Infections, Women’s health & pregnancy clinical trials.

This trial is testing an experimental treatment called C14 to see how well it works and how safe it is for women with an HPV infection. If you are a sexually active woman aged 30 or older, this study may be an option to explore.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
66 people
Ages
30 years to 65 years
Study type
Interventional

Who can take part

  • You are a woman and are sexually active.
  • You are at least 30 years old.
  • You are willing to give your informed consent to join the study.
  • You are not pregnant, breastfeeding, or in the post-partum period.
  • You have not had cervical surgery before, have no history of serious diseases, and are not using other antiviral medications.
  • You do not have a known allergy to the study product C14.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06144229Enrolling by invitation
HPV Vaccine in Women with HIV

This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.

Denver, Colorado
NCT05385406Recruiting
HPV screening with different ways to check for cervical problems

This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.

Dschang, Menoua
NCT07214584Recruiting
Using blood and cervical tests to track cervical cancer treatment response

This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.

Gainesville, Florida
NCT05829629Recruiting· Phase 1
Test of an HPV vaccine-like treatment for HPV16 in women

This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.

Bratislava
NCT07077980Not yet recruiting
HPV vaccine trial for cervical cancer patients

This trial is testing a new vaccine designed to help your immune system fight cervical cancer caused by HPV types 16 or 18. It is for women who are receiving standard treatment like surgery, chemotherapy, or radiation.

Hefei, Anhui
NCT07281430Recruiting
HPV self-test for cervical cancer screening

This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.

Birmingham, Alabama

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.